Operator
Good afternoon, and welcome to the Polarean Imaging plc Investor Presentation. [Operator Instructions] Earlier than we start, I might prefer to submit the next ballot. I might now like at hand you over to Christopher Von Jako, CEO. Good afternoon, sir.
Christopher Von Jako
CEO & Director
Thanks a lot. I respect it. So hiya. As talked about, my identify is Chris Von Jako. I am the CEO of Polarean, and I am joined at present by our CFO, Chuck Osborne. So thanks for taking the time to be with us. I am going to start with an outline and a few further context on the RNS we launched this morning. And after that, I am going to stroll by an up to date presentation, each as a refresher for these aware of Polarean and as an introduction for any new to the story. Lastly, Chuck and I’ll take a lot of questions on the finish of the presentation.
So earlier than I start, simply as a reminder, these are the traditional disclaimers. We’re revolutionizing pulmonary drugs with our FDA-approved Xenon MRI platform. It’s the solely noninvasive radiation-free know-how that exhibits the total image of lung operate. So utilization is rising throughout our main tutorial facilities, each in medical in addition to analysis. And as you could know, our know-how is accessible to be used on all 3 main MRI distributors. So that features Philips, GE and Siemens.
Reimbursement is lively, which is nice for us, and medical websites are billing and getting paid for Xenon MRI exams. In March, we introduced a 3rd income vertical in our pharma trial, which is in pharma trials, the place we additionally signed our first multicenter trial, and we proceed to construct a
